a nonsignificant trendp = 0.09
More recently, ECPR was compared to CCPR for witnessed, refractory OHCA (i.e., prolonged cardiac arrest and cardiac arrest without ROSC in the field) in a single-center trial that reported a nonsignificant trend towards survival with good neurologic outcome at 180 days (n = 256, 31.5% vs. 22%, p = 0.09) [ 21 ].